Skip to main
NTR
NTR logo

Nutrien (NTR) Stock Forecast & Price Target

Nutrien (NTR) Analyst Ratings

Based on 29 analyst ratings
Buy
Strong Buy 24%
Buy 28%
Hold 41%
Sell 3%
Strong Sell 3%

Bulls say

Nutrien is positioned for steady growth through 2025 and 2026, driven by the increasing adoption of higher-margin proprietary products and biologicals alongside improving crop prices in the Americas. The company is benefitting from structural enhancements in its Retail business, particularly in Brazil, which has resulted in significant margin recovery and an anticipated year-over-year core Retail EBITDA growth of $125 million. Additionally, Nutrien's strong market position in potash, driven by improved affordability and strong demand from key markets like Brazil and China, supports its positive outlook amid favorable agricultural economics.

Bears say

Nutrien has experienced a decline in several key financial metrics that contribute to a negative outlook, including a projected drop in ammonia margins by 36%, reflecting weakening nitrogen prices over the next 16 months. Moreover, the company's mid-cycle EBITDA multiple has declined from a historical average of 8.0x to 6.5x, indicating reduced investor confidence and profitability expectations. Additionally, uncertainties surrounding tariffs and weak market conditions in Brazil further exacerbate concerns regarding future crop input spending, limiting the potential for revenue growth.

Nutrien (NTR) has been analyzed by 29 analysts, with a consensus rating of Buy. 24% of analysts recommend a Strong Buy, 28% recommend Buy, 41% suggest Holding, 3% advise Selling, and 3% predict a Strong Sell.

This aggregate rating is based on analysts' research of Nutrien and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Nutrien (NTR) Forecast

Analysts have given Nutrien (NTR) a Buy based on their latest research and market trends.

According to 29 analysts, Nutrien (NTR) has a Buy consensus rating as of Jul 10, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $64.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $64.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Nutrien (NTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.